If you look at other drug trials you will see that many symptoms are reported by people on the placebo.
That will include dizziness.
The numbers reported per arm will be different, but that won't be known until the results are analyzed.
There seems to be an assumption that the placebo arm people will not report any side effects. That is very unlikely.
While the findings are only anecdotal at this stage, improvements have been noticed among individuals involved, said principal investigator Associate Professor Stephen Macfarlane.
“We’ve certainly seen individual patients, who both seem to be getting side effects from the drugs and who have shown significant improvements,” Professor Macfarlane told AAA.
“The findings we’ve got can only be anecdotal because it’s a double-blind trial, which means at the moment, we don’t know who’s taking the actual drug and who’s taking the placebo,” said Professor Macfarlane, head of clinical services at HammondCare.
Market Data 
Markets 
AI
